XML 210 R21.htm IDEA: XBRL DOCUMENT v3.25.0.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Pay vs Performance Disclosure    
Net loss attributable to Arrowhead Pharmaceuticals, Inc. $ (173,085) $ (132,864)